Pharmaceutical Technology

MAY 29, 2023

GlobalData’s Blockchain Market Size, Share, Trends, and Segment Forecast to 2030 report offers insights on application of blockchain in healthcare and other key sectors. GlobalData identified 1 blockchain-related sentences in the company's filings - 0% of all sentences - and an increase of 100% in Q1 2023 compared with Q1 2022.

Pharmaceutical 52

Pharmaceutical Marketing Competition Medicine 52

pharmaphorum

JANUARY 29, 2023

With the population ageing, the need for healthcare is growing fast: between 2015 and 2050, the proportion of the world’s population over 60 years old will nearly double from 12% to 22%, according to the World Health Organization. Secondly, pressure on healthcare spending is leading to greater consolidation.

Healthcare 89

Healthcare Healthcare Manufacturing Marketing 89

Infuse Medical

JULY 4, 2024

VR in healthcare is doing magic by transforming the conventional working environment to the next level. Brief Overview of the Importance of Medical Device Maintenance Medical device maintenance ensures patient safety, operational efficiency, and regulatory compliance in healthcare settings. What is VR Training?

Training 52

Training Medical Healthcare Healthcare 52

European Pharmaceutical Review

FEBRUARY 12, 2024

Liam Dunne, MSD Biotech Site Lead, explains that the site operates at the forefront of science and technology with 15,000L-scale, repeatable, robust manufacturing processes to produce highly sensitive monoclonal antibodies (mAbs). How does it do this? Since 2021, Liam Dunne is the site head of MSD Biotech in Dublin.

Manufacturing 98

Manufacturing Medicine Leads Patients 98

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. The MFPs will be announced publicly in September 2024 and go into effect on January 1, 2026.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. billion by 2026, according to research by the Business Research Company. billion in 2021 to $9.23 References.

Marketing 98

Marketing Pharma Healthcare Healthcare 98

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Contact us to learn more about the Mainland China healthcare market and disease-specific trends.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

Clarivate

OCTOBER 25, 2023

The initial list, which takes effect in 2026, has the potential to roil formularies since it includes a mix of high-volume, preferred brands and a group of high-cost specialty drugs for autoimmune conditions (psoriasis) and cancer. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

AUGUST 7, 2024

The pricing estimates are not guaranteed, leading to potential unexpected expenses. The reliance on AWP and MAC, which often exceed actual pharmacy costs, may lead to higher expenses for plan sponsors. OptumRx Cost Advantage (launched in April, 2023) A flexible, pass-through model using average ingredient costs.

Retail 59

Retail Marketing Competition Biopharma 59

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

pharmaphorum

JANUARY 18, 2023

That pressure can lead to diagnostic errors, with a 2018 study suggesting that there are 40 million errors involving imaging worldwide every year. billion) in 2021, around 10% of the group’s total healthcare revenues. The business generated sales of €1.8 billion (approximately $1.9

Medical 59

Medical Pharma Media Sales 59

pharmaphorum

JULY 26, 2022

The Dutch biotech will book around $235 million from a private placement led by Frazier Healthcare Partners and Bain Capital Life Sciences and funds held in Frazier’s trust account. So why will obicetrapib avoid the pitfalls of its predecessors?

Side effects 52

Side effects Safety Pharma Patients 52

Medico Reach

MARCH 24, 2023

As a result, a global approach to healthcare has emerged continually over the years. This global approach to healthcare is known as precision medicine which has emerged in treatments like immunotherapy. It is estimated that global oncology spending will exceed $300 billion by 2026.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

Medico Reach

MARCH 24, 2023

As a result, a global approach to healthcare has emerged continually over the years. This global approach to healthcare is known as precision medicine which has emerged in treatments like immunotherapy. It is estimated that global oncology spending will exceed $300 billion by 2026.

Marketing 52

Marketing Medicine Healthcare Healthcare 52

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. United States Specialty Pharmaceuticals Market & Forecast 2020-2026,” BusinessWire, December 8, 2020. IQVIA Institute, March 2022.

Prescription 52

Prescription Medical Patients Distribution 52

Clarivate

SEPTEMBER 5, 2024

Starting in 2026, the first ten self-administered Part D drugs in the law’s cross hairs will receive price cuts of 38%-79%. With the passage of the Inflation Reduction Act (IRA), the United States government gained the ability to directly negotiate drug prices with manufacturers.

Insurance 52

Insurance Marketing Manufacturing Prescription 52

Clarify Health

MAY 4, 2022

Population health management is best supported by a data-driven approach with a structured analytics process driven by skilled and competent healthcare leaders and clinicians. Reports estimate that the healthcare analytics market size is expected to grow to $75.1 billion by 2026.

Management 52

Management Healthcare Healthcare Training 52

Clarify Health

MAY 4, 2022

Population health management is best supported by a data-driven approach with a structured analytics process driven by skilled and competent healthcare leaders and clinicians. Reports estimate that the healthcare analytics market size is expected to grow to $75.1 billion by 2026. Get valuable Insights delivered to your inbox.

Management 52

Management Healthcare Healthcare Training 52

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. That impacts launches most. Lastly, the growing economic crisis creates increasing challenge for medicines funding.

Doctors 59

Doctors Medicine Marketing Sales 59

pharmaphorum

JANUARY 4, 2023

The CGT market in Europe, for example, is projected to increase by 23% by 2026. Robust cryogenic infrastructure in strategic locations across the globe – ideally close to processing facilities and healthcare providers – is necessary to enable timely and reliable access to these therapies around the world and accelerate time to treatment.

Transportation 90

Transportation Manufacturing Patients Networking 90

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. What is the Global Healthcare and Pharma Market Q2 Outlook?

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. What is the Global Healthcare and Pharma Market Q2 Outlook?

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52

World of DTC Marketing

JULY 28, 2022

Yet, high drug prices lead to soaring out-of-pocket costs , dangerous drug rationing , and a depletion of limited financial resources —especially for those with fixed incomes. Reforms to let Medicare negotiate prices, cap out-of-pocket costs for prescription drugs, and limit insulin cost-sharing would make lifesaving drugs more affordable.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

Clarivate

OCTOBER 17, 2024

Healthcare delivery has not been the hottest topic on the campaign trail this election season, despite sharp policy differences between the candidates and parties. These prior actions align with the Biden Administration’s policy of strict antitrust enforcement, particularly concerning healthcare. During the Sept.

Healthcare 52

Healthcare Healthcare Government Insurance 52